Blood Urea Nitrogen Diagnostics Market size was valued at USD 1.92 billion in 2023 and is anticipated to reach USD 4 billion by 2036, expanding at around 5.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of blood urea nitrogen diagnostics is assessed at USD 2.01 billion. The growth of the market can be attributed to an increased number of patients with kidney diseases. The blood urea nitrogen diagnostics are extensively used to determine the functioning of blood by measuring urea in the blood. As per the statistics given by the International Society of Nephrology, more than 850 million people worldwide have kidney ailments. On account of this, the global market is anticipated to grow during the forecast period. Furthermore, rising government initiatives are also projected to augment the market growth. The International Society of Nephrology and the International Federation of Kidney Foundation promulgate World Kidney Day every 2nd Thursday in march. The global campaign is celebrated to raise awareness for the importance of kidneys’ overall health. People are becoming aware of kidney tests and are getting regular checkups, which is projected to boost the global blood urea nitrogen diagnostics market growth. Additionally, the soaring health expenditure is anticipated to fuel the market growth. The data released by the World Bank in 2019 states that 9.84% of the total world GDP is the current health expenditure. The growing geriatric population is also one of the prominent reasons which are expected to foster the global market growth during the forecast period.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
5.8% |
|
Base Year Market Size (2023) |
USD 1.92 billion |
|
Forecast Year Market Size (2036) |
USD 4 billion |
|
Regional Scope |
|
The market is segmented by application into hospitals, laboratories, clinics, and others. Out of which, the hospital sub-segment is anticipated to hold the largest share in the global blood urea nitrogen diagnostics market on account of the rising number of patients visiting the hospitals. With the increasing awareness amongst the people regarding health, they are becoming proactive and opting for regular health check-ups and doctor visits more frequently.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
Regionally, the global blood urea nitrogen diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is set to hold largest revenue share by 2036, propelled by presence of the trailblazing healthcare infrastructure. Furthermore, the rising cases of kidney diseases are also expected to boost the growth of global market. The data published by the Centers for Disease Control and Prevention show that 37 million adults in the USA are estimated to have chronic kidney diseases. Furthermore, the government expenditure in the healthcare sector is considerably high in the region, which is also estimated to uplift the global blood urea nitrogen diagnostics market growth.
Moreover, the Asia Pacific region is also projected to exhibit significant growth in the global market during the forecast period, owing to high population of older adults, accompanied with the overall increasing population in the region. The United Nations Population Fund states that the Asia and Pacific region has 60% of the world’s total population. The large population of the region is estimated to fuel the global blood urea nitrogen diagnostics market growth during the forecast period.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?